Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISAL 2023 | ISAL 2023: looking forward to this year’s meeting and insights into the program

Wolfgang Hiddemann • 16 Mar 2023
ISAL 2023
Acute Myeloid Leukemia Leukemia

Wolfgang Hiddemann, MD, PhD, Ludwig-Maximilians University, Munich, Germany, shares some insights into the upcoming 18th International Symposium on Acute Leukemias (ISAL XVIII), which is being held in Munich, Germany, on March 19-22, 2023. Prof. Hiddemann comments on the success of this meeting, as well as some of the topics and sessions that will take place, from basic biology, to clinical trial updates, and more.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Wolfgang Hiddemann

2:52
International Symposium on Acute Leukemias: key messages from the 2019 meeting
Wolfgang Hiddemann • 15 Mar 2019
1:04
Acute leukemia research at LMU Munich
Wolfgang Hiddemann • 14 Mar 2019
8:26
Challenging the norms for elderly AML treatment: clinical trials & intensive therapy
Alan Burnett et al. • 17 Feb 2018
11:35
Optimization of standard AML treatment: APL advances, adverse cytogenetics & post-remission therapy
Alan Burnett et al. • 2 Mar 2018

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals